|
Visa & Mastercard Accepted
|
For Immediate
Professional Investigations call 1-800-820-7006
 Through
extensive research it has been brought to our attention
here at Tim D. Wilson Investigations that the dangerous
drug known as Trasylol may be the cause of many deaths.
We are extremely blessed to have the opportunity to work
with leading physicians and top attorneys nation wide to
help the families who have suffered tragic losses, due
to this defective drug, receive the compensation that
they deserve.
Trasylol is the brand name of the drug aprotnin. This
drug is also known as bovine pancreatic trypsin
inhibitor, or BPTI. The manufacture of this drug is
Bayer. BPTI is a protein that is used as a medication
during major surgeries to help reduce severe bleeding.
In several independent studies and studies conducted by
Bayer, Trasylol was found to have greatly increased the
risk of kidney failure and death during and after major
surgeries. One of the most common surgeries in which
Trasylol has been known to be used is open heart
surgery.
Bayer failed to report major details of the side effects
of this drug. During a study conducted by Bayer,
Trasylol was found to have greatly increased the risk of
severe kidney failure, strokes, and heart failure.
During their study, Bayer looked at 78,000 patients who
had been administered the drug Trasylol. This study
revealed that the risk of death in patients who were
administered Trasylol was 64 percent higher that those
who were administered comparable drugs. Although Bayer
claims that the lack of this information reported to the
FDA was an oversight, we believe that they should be
held liable for their mistake.
In September of 2006 the FDA decided to update the label
of Trasylol, stating that it greatly increased the risk
of kidney failure and death. The type of warning that
the FDA required was called a black box warning. The
black box warning is the strictest warning that the FDA
requires. In September of 2007 the FDA agreed that
Trasylol was causing dangerous and even fatal side
effects, but did not request its removal from the
market. It was no until several months after this
decision that the FDA learned of the negative results
with a Canadian study. When the FDA learned of the
negative results in the Canadian study, they requested
Bayer to stop all sales of Trasylol.
A study that was performed from 1996 to 2005 by the Duke
University Medical Center revealed that patients who
were administered Trasylol were at a 2 ½ times greater
risk of dying within 30 days after major surgeries than
those who were administered other excessive bleeding
drugs. This study also revealed that at one year 16
percent of patients who were administered Trasylol died,
which is also 2 ½ times that of those who were
administered comparable drugs. This evidence is
overwhelmingly alarming.
A doctor by the name of Dennis Mangano warned the FDA of
the negative results from his independent study in 2006.
It is brought to our attention that the FDA ignored his
warning thus causing them and Bayer to be responsible
for the deaths of many thousands of patients. If you
have suffered from defective Trasylol, or have
experienced the loss of a loved who was administered
Trasylol during major surgery, please contact our office
so that we can fight for the compensation that you
deserve and help to balance the scales of justice.
Other Pharmaceutical
Investigations / Research:
Call Info:
800-820-7006 | Toll Free
713-956-1111 | Local
TimWilsonInvestigations.com |
